CCN2 and metabolic dysfunction-associated steatotic liver disease: Down-regulation of CTGF could be considered as a potential biomarker to predict a non/mild steatotic liver from NAFLD donors, and CTGF up-regulation could indicate a risk of a moderate/severe steatotic liver that requires further examination prior to graft selection (Fig. 7).